Chiral Technologies, Inc. | Authors

Articles

App Note: The Chiral Separation of Remdesivir and Several of its Key-Starting Materials

This application note shares new chiral separations for the anti-viral, COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials.

The Chiral Separation of Remdesivir and Several of Its Key-Starting Materials

See chiral separations for anti-viral COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials, on Daicel chiral and achiral columns.

Separation of 2-Phenylbutyrophenone on Daicel’s New Chiralpak® Ij

The launch of CHIRALPAK® IJ gives access to an expanded range of solvents, which yields new separation not previously achievable on the coated CHIRALCEL® OJ.

Separation of the Enantiomers of (+/-) Δ8-THC and (+/-) Δ9-THC

Daicel’s CHIRALPAK® IF proven to perform the difficult separations of cannabinoids Δ8-THC and Δ9-THC.